||EPS - Basic
||Market Cap (m)
Victrex Share Discussion Threads
Showing 501 to 522 of 525 messages
|I bought quite a few around £14 in May/ June. Always in market for more at that or lower based on these results.|
|The currency impact will certainly be positive, circa 97% of sales are outside of the UK. Perhaps a ten to fifteen percent uplift on exchange rate depending on how much they have used hedges. They have also signaled some cost cutting schemes too.
The watch out for me is how demand in the consumer sector holds up. This accounted for around 40% of sales (1680/4217 tonnes) in 2015. We know from the trading statement that consumer sector sales were 30% lower in 2016 compared to 2015 and are expected to be significantly lower still in 2017. VCT have reported a 4% fall in revenue in 2016, so growth elsewhere was not sufficient to offset the consumer segment. With a further fall in demand predicted in this sector in 2017, VCT are going to have to perform extremely well to maintain their top and bottom line at existing level let alone grow them.
Trading at circa 18x 2016 EPS, with a high degree of uncertainty and potentially limited short term growth prospects, VCT currently is too expensive for my liking.|
Ha ha. I had circa 8k shares. Yep, I would be better of if I had sold later in the day (an hour, perhaps a lesson) but my reason for exiting is independent of the share price I will keep this on my watch list as I like the company. What I do not like, hence exiting, is the lack of visibility in the consumer segment of future revenue and hence overall profitability.
I will take my 10% profit and move on. I wish those that hold here the very best.
|Now 1753. Hope you did not have too large a holding.|
|Sold out this morning (@1621), taking a circa 10% profit. The lack of visibility on revenues in the consumer segment materially increases the downside risk, so no longer one for me.
|Update from N+1 Singer: Https://www.research-tree.com/companies/uk/specialty-chemical/victrex-plc/research/n-1-singer-victrex-strong-q4-delivered-meeting-fy-expectations/CC17_5_1|
|Certainly going somewhere fast today following trading update.|
|......somewhat disappointed with these......going nowhere fast !|
|Been watching this one for some time and have today taken up a modest position. Good ROCE.|
|"In the wake of the EU referendum result, our view of the UK chemicals sector remains relatively upbeat. The companies we cover (Croda, Elementis, Scapa, Synthomer, Victrex, Zotefoams) generally have limited domestic exposure and plenty to gain on transactional and/or translational FX exposure. The main beneficiary of FX is Victrex, where as a rule of thumb, we would expect a 10% sterling devaluation to increase Group PBT by 10%, all else being equal. An isolated period of disruption/ contraction in the UK could therefore be..." Broker note out from N1Singer: Https://www.research-tree.com/company/GB0009292243|
|Article in Evening Standard may be of interest re shorting stock by some hedge funds.
|deadly - yes, looks like some analysts were overly pessimistic. As I said in post 11 things are very uncertain right now. But BREXIT will be decided in a few weeks, that's one variable out of the way. (Unless 'they' don't like the result and decide to copy the Irish and try again next year ha ha)|
|poor results today but price rises. Must be better than expected?|
|Taken a bit of a hit today. The oil & gas market is going to take time to sort. The Saudis and others playing silly games. Also I'm not all that optomistic on a 'consuner' recovery anytime soon.
Next divi(which is only the interim)is quite a long way off so I'm just going to resist the temptation to top up. Good company, good product, but markets are very jittery right now.|
7 April 2016
Victrex plc: H1 pre-close trading update
'On track for expected H2 improvement'
Victrex plc, an innovative world leader in high performance polymer solutions, today releases its first half year (H1) and pre-close trading update ahead of its interim results on 16 May 2016.
In line with the Group's guidance at its Q1 IMS, Victrex's first half year performance was down on the prior year. Q2 was robust with volumes excluding Consumer Electronics flat compared to the record prior year, despite the weaker performance in Oil & Gas.
The re-phasing of Consumer Electronics volumes to the second half year (H2), together with the tougher first half comparatives and worsening outlook in Oil & Gas, led to Group revenue declining by 11% to £117.0m (H1 2015: £131.6m). H1 Group volumes were down 13% to 1,770 tonnes (H1 2015: 2,028 tonnes).
We remain encouraged that the performance in our industrial markets outside of Electronics and Oil & Gas was solid, with Transport markets in growth. In our Medical business (Invibio), performance in our core Spine market was broadly similar to the prior year. Invibio revenue for the first half was £25.2m (H1 2015: £25.9m).
Our expectation for an improved second half year reflects both the robust Q2 performance and the re-phasing of Consumer Electronics volumes. Consumer Electronics volumes will be phased well into the second half, ahead of product launch cycles. This opportunity remains attractive for the current year and we expect to have a better view on the scale of volumes by our May interim results. This will provide a clearer view of whether Consumer Electronics has the potential to be similar to the second half of 2015.
David Hummel, Chief Executive of Victrex, said: "We retain our view of an overall improvement in the second half and are comfortable with current expectations for the full year as a whole."|
|My understanding is that they will pay out half of net cash in special dividends. After the big payment last year cash is down but in theory lower capex and assuming their good cash flow continues next year or two this should replenish the coffers and keep some extra dividends coming.
In fact I just got a call from them in response to a query on arrangements for the AGM. It is in a London hotel on Wednesday Feb 10th but I cannot go. If anyone is able to attend please post here if anything of note...
Frankly doesn't matter so much what one holds at present, all getting bashed (except golds). Tin helmet time.|
|srichardson8 - I can't add anything to the figures, there was talk last November about a 'new capital framework' which would enable future returns to shareholders via 'special dividends' of course I get the feeling that this would only happen if markets were 'normal' and right now I don't think they are.
I've been a small private investor for a long time and I don't think I've ever seen so many negative trends happening at the same time (China, commodities, oil, Europe, not to mention the BREXIT scenario)
Logic says that one or more of these should resolve in 2016 let us hope so.|
|er what is cpr?
this co is an old friend that I bought back into in December and thus nursing a pretty awful price drop.
I see all the brokers put out notes in early Jan, esp JPM, at best lukewarm at worst downright negative. I suppose the large special div has gone and there is presumably some further deterioration in the end markets (?) - medical, aero & smartphone (?) perhaps, as well as more obviously energy. Against that is the reasonable looking forward ratings, strong margins and possibly forex benefit on the P & l. And progressive dividend policy combining with strong cash flow. If anyone can add any light would be much appreciated.|
|could do with some cpr here|
|low oil price must play well for margins|
|Chinese stock market is closed again.....bad idea .|
|Any thoughts on the fall here?|